Vanguard Fiduciary Trust
MBOT icon

Vanguard Fiduciary Trust’s Microbot Medical MBOT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841K Buy
431,033
+30,808
+8% +$62.8K ﹤0.01% 3086
2026
Q1 		$965K Buy
+400,225
New +$894K ﹤0.01% 2927

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's MBOT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Microbot Medical (MBOT) stake by 7.7% in Q2 2026, buying an estimated $62.8K and bringing the position to 431,033 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

Vanguard Fiduciary Trust first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $965K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Vanguard Fiduciary Trust held 431,033 shares of Microbot Medical worth $841K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 30,808 Microbot Medical shares in Q2 2026, an estimated $62.8K.
  • Microbot Medical made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3086 holding.
  • Vanguard Fiduciary Trust first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Microbot Medical position peaked at $965K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.